BEIJING TONGRENTANG CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.48 CNY | -0.49% |
|
+5.08% | -17.17% |
| 05-01 | Tong Ren Tang Registers Danggui Buxue Granules in Hong Kong | MT |
| 04-30 | Tong Ren Tang's Q1 Profit Jumps 10%, Revenue Rises 2% | MT |
| Sales 2024 * | 20.11B 2.78B 222B | Sales 2025 * | 22.68B 3.14B 251B | Capitalization | 61B 8.44B 674B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.89B 261M 20.89B | Net income 2025 * | 2.26B 313M 24.97B | EV / Sales 2024 * | 2.43 x |
| Net cash position 2024 * | 12.23B 1.69B 135B | Net cash position 2025 * | 13.88B 1.92B 153B | EV / Sales 2025 * | 2.08 x |
| P/E ratio 2024 * |
32.2
x | P/E ratio 2025 * |
27.3
x | Employees | 16,777 |
| Yield 2024 * |
0.72% | Yield 2025 * |
1.12% | Free-Float | 47.55% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.49% | ||
| 1 week | +5.08% | ||
| Current month | +5.08% | ||
| 1 month | +7.75% | ||
| 3 months | +1.62% | ||
| 6 months | -12.39% | ||
| Current year | -17.17% |
1 week
42.88
45.27
1 month
40.3045.27
Current year
39.7155.74
1 year
39.7162.50
3 years
28.3564.28
5 years
23.2564.28
10 years
16.3564.28
| Managers | Title | Age | Since |
|---|---|---|---|
Chao Hua Zhang
CEO | Chief Executive Officer | 50 | 24/06/21 |
Li Yang
BRD | Director/Board Member | 46 | 24/06/21 |
Kai Ting Wen
BRD | Director/Board Member | 46 | 01/04/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Ying Yang
BRD | Director/Board Member | 70 | 08/01/23 |
Yi Zang
BRD | Director/Board Member | 47 | 12/06/18 |
Bai Gang Liu
BRD | Director/Board Member | 56 | 12/06/18 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.17% | 2 M€ | -14.14% | ||
| 1.07% | 0 M€ | -12.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 44.48 | -0.49% | 10,057,440 |
| 09/05/24 | 44.7 | -0.18% | 9,483,577 |
| 08/05/24 | 44.78 | -0.33% | 9,513,196 |
| 07/05/24 | 44.93 | +0.74% | 15,753,580 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotes
BEIJING TONGRENTANG CO., LTD is a China-based company principally engaged in the production and sales of traditional Chinese patent medicines. The Companyâs main products consist of liuwei dihuang series, tongren dahuoluo series, tongren niuhuang qingxin series, angong niuhuang series and donkey-hide gelatin series. The Company distributes its products under the brand of Tongrentang. The Company is also involved in the operation of Tongrentang drug stores. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
27/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
44.48
CNY
Average target price
53.25
CNY
Spread / Average Target
+19.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.17% | 8.44B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- 600085 Stock
